Comprehensive Digestive Analysis

Comprehensive Digestive Analysis

Christine Rosche, MPH,CNS,CBT is a Digestive Health Expert with 25 years experience in the field. Research now shows that many chronic conditions such as Inflammatory disorders/auto immune disorders and degenerative disease begins in the digestive system.

• The Digestive System contains 80 percent of your Immune system.
• You manufacture most neurotransmitters you need for optimal brain chemistry support in the digestive system.
• Many Brain disorders, ADD, ADHD and depression, anxiety, panic disorder have digestive issues as part of their origin/cause.
• Your gut is a key player in detoxification and the strength of your immune system.

Christine offers an easy to take, in-home test, the Comprehensive Digestive Stool Analysis which evaluates the following and more:

• Status of Beneficial Flora and overgrowth Dysbiotic bacteria
• What specific probiotics you need to heal your gut
• What enzymes you need for optimal digestion and absorption
• What is the status of your gut immune system and how to build gut immunity
• How to heal intestinal permeability – the root cause of all auto-immune disorders such as MS, Lupus, Hashimotos Thyroiditis

The Test Looks At:

• Benefical/Imbalanced Flora
• Complete Parasitology
• Gut Bacteria
• Yeast Culture
• Gut Immunology
• Digestion Markets
• Absorbtion Markers
• Ph
• Red Blood Cells
• Short Chain Fatty Acids

With your test result, you will receive specific recommendations and supplements for correcting imbalances. This test is the state of the art and is used in Europe and other countries where the government pays for health insurance. With the findings of this test you can see imbalances and correct them years before they show up on standard medical testing and before they become costly health conditions. Gastrointestinal (GI) complaints are among the most common reasons that patients seek medical care. Symptoms associated with GI disorders include persistent diarrhea, constipation, bloating, indigestion, irritable bowel syndrome and malabsorption. The Comprehensive Stool Analysis with Parasitology x1, 2, or 3 (CSAP1, 2, 3) may be used to assess digestive and absorptive functions, the presence of opportunistic pathogens and to monitor the efficacy of therapeutic remediation of GI disorders.

Cornerstones of good health include proper digestion of food, assimilation of nutrients, exclusion of pathogens and timely elimination of waste. To obtain benefits from food that is consumed, nutrients must be appropriately digested and then efficiently absorbed into portal circulation. Microbes, larger sized particles of fiber, and undigested foodstuffs should remain within the intestinal lumen. Poor digestion and malabsorption of vital nutrients can contribute to degenerative diseases, compromised immune status, and nutritional deficiencies. Impairment of the highly specific nutrient uptake processes, or compromised GI barrier function (as in “leaky gut syndrome”) can result from a number of causes including: low gastric acid production, chronic maldigestion, food allergen impact on bowel absorptive surfaces, bacterial overgrowth or imbalances (dysbiosis); pathogenic bacteria, yeast or parasites and related toxic irritants, and the use of NSAID’s and antibiotics.

Impairment of intestinal functions can contribute to the development of food allergies, systemic illnesses, autoimmune disease, and toxic overload from substances that are usually kept in the confines of the bowel for elimination. Efficient remediation of GI dysfunctions incorporates a comprehensive guided approach that should include consideration of elimination of pathogens and exposure to irritants, supplementation of hydrochloric acid, pancreatic enzymes and pre- and probiotics, and repair of the mucosal barrier. The Comprehensive Stool Analysis with Parasitology x1, 2, or 3 is an invaluable non-invasive diagnostic assessment that permits practitioners to objectively evaluate the status of beneficial and imbalanced commensal bacteria including Clostridium species, pathogenic bacteria, yeast/fungus and parasites. Precise identification of pathogenic species and susceptibility testing greatly facilitates selection of the most appropriate pharmaceutical or natural treatment agent(s).

Important information regarding the efficiency of digestion and absorption can be gleaned from the measurement of the fecal levels of elastase (pancreatic exocrine sufficiency), muscle and vegetable fibers, carbohydrates, and steatocrit (% total fat). Inflammation can significantly increase intestinal permeability and compromise assimilation of nutrients. The extent of inflammation, whether caused by pathogens or inflammatory bowel disease (IBD), can be assessed and monitored by examination of the levels of biomarkers such as lysozyme, lactoferrin, white blood cells and mucus. These markers can be used to differentiate between inflammation associated with potentially life threatening inflammatory bowel disease (IBD), which requires life long treatment, and less severe inflammation that can be associated with the presence of enteroinvasive pathogens. Lactoferrin is only markedly elevated prior to and during the active phases of IBD, but not with IBS. Monitoring fecal lactoferrin levels in patients with IBD can therefore facilitate timely treatment of IBD, and the test can be ordered separately. Since the vast majority of secretory IgA (sIgA) is normally present in the GI tract where it prevents binding of pathogens and antigens to the mucosal membrane, it is essential to know the status of sIgA in the gut. sIgA is the only bona fide marker of humoral immune status in the GI tract.